Sfoglia per Autore
Anterior and posterior vaginal myomectomy: A new surgical technique
2006-01-01 Carminati, R.; Ragusa, A.; Giannice, R.; Pantano, F.
New developments of aminobisphosphonates: the double face of Janus
2007-01-01 Santini, D; Galluzzo, S; Vincenzi, B; Schiavon, G; Fratto, E; Pantano, F; Tonini, G
Molecular prognostic factors in patients with pancreatic cancer
2007-01-01 Tonini, G; Pantano, F; Vincenzi, B; Gabbrielli, A; Coppola, R; Santini, D
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis
2008-01-01 Vincenzi, B; Patti, G; Galluzzo, S; Pantano, F; Venditti, O; Santini, D; Ruzzo, A; Schiavon, G; Caraglia, M; Marra, M; Graziano, F; Tonini, G
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients
2008-01-01 Santini, D; Pantano, F; Vincenzi, B; Loupakis, F; Caraglia, M; Falcone, A; Tonini, G
Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer
2008-01-01 Vincenzi, B; Schiavon, G; Pantano, F; Santini, D; Tonini, G
Stevens-Johnson syndrome associated with reduced tear production complicating the use of cetuximab and panitunumab
2009-01-01 Pantano, F; Silletta, M; Iovieno, A; Vincenzi, B; Santini, D; Galluzzo, S; Bonini, S; Tonini, G
PANCREAS CANCER
2009-01-01 Tonini, G; Pantano, F
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population
2009-01-01 Angeletti, S; Galluzzo, S; Santini, D; Ruzzo, A; Vincenzi, B; Ferraro, E; Spoto, C; Lorino, G; Graziano, N; Calvieri, A; Magnani, M; Graziano, F; Pantano, F; Tonini, G; Dicuonzo, G
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients
2009-01-01 Pantano, F; Baldi, A; Santini, D; Vincenzi, B; Borzomati, D; Vecchio, Fm; Castri, F; Antinori, A; Caraglia, M; Magistrelli, P; Coppola, R; Tonini, G
Potential role of everolimus in inducing cholestasis
2010-01-01 Pantano, F; Santini, D; Guida, F; Vincenzi, B; Tonini, G
CETUXIMAB: From bench to bedside
2010-01-01 Vincenzi, B.; Zoccoli, A.; Pantano, F.; Venditti, O.; Galluzzo, S.
New molecular targets in bone metastases
2010-01-01 Santini, D; Galluzzo, S; Zoccoli, A; Pantano, F; Fratto, Me; Vincenzi, B; Lombardi, L; Gucciardino, C; Silvestris, N; Riva, E; Rizzo, S; Russo, A; Maiello, E; Colucci, G; Tonini, G
TUMORI NEUROENDOCRINI
2011-01-01 Tonini, G; Pantano, F
Monoclonal antibodies
2011-01-01 Tonini, G; Imperatori, M; Zoccoli, A; Iuliani, M; Pantano, F
New targets, new drugs for metastatic bone pain: a new philosophy
2011-01-01 Pantano, F; Zoccoli, A; Iuliani, M; Lanzetta, G; Vincenzi, B; Tonini, G; Santini, D
Emerging Therapeutic Targets in Osteoncology
2011-01-01 Santini, D; Pantano, F; Vincenzi, B; Tonini, G
Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence
2011-01-01 Tonini, G; Fratto, Me; Imperatori, M; Pantano, F; Vincenzi, B; Santini, D
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients
2011-01-01 Santini, D; Schiavon, G; Vincenzi, B; Gaeta, L; Pantano, F; Russo, A; Ortega, C; Porta, C; Galluzzo, S; Armento, G; La Verde, N; Caroti, C; Treilleux, I; Ruggiero, A; Perrone, G; Addeo, R; Clezardin, P; Onetti Muda, A; Tonini, G
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases
2011-01-01 Santini, D; Perrone, G; Roato, I; Godio, L; Pantano, F; Grasso, D; Russo, A; Vincenzi, B; Fratto, Me; Sabbatini, R; Della Pepa, C; Porta, C; Del Conte, A; Schiavon, G; Berruti, A; Tomasino, Rm; Papotti, M; Papapietro, N; Onetti Muda, A; Denaro, V; Tonini, G.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Anterior and posterior vaginal myomectomy: A new surgical technique | 1-gen-2006 | Carminati, R.; Ragusa, A.; Giannice, R.; Pantano, F. | |
New developments of aminobisphosphonates: the double face of Janus | 1-gen-2007 | Santini, D; Galluzzo, S; Vincenzi, B; Schiavon, G; Fratto, E; Pantano, F; Tonini, G | |
Molecular prognostic factors in patients with pancreatic cancer | 1-gen-2007 | Tonini, G; Pantano, F; Vincenzi, B; Gabbrielli, A; Coppola, R; Santini, D | |
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis | 1-gen-2008 | Vincenzi, B; Patti, G; Galluzzo, S; Pantano, F; Venditti, O; Santini, D; Ruzzo, A; Schiavon, G; Caraglia, M; Marra, M; Graziano, F; Tonini, G | |
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients | 1-gen-2008 | Santini, D; Pantano, F; Vincenzi, B; Loupakis, F; Caraglia, M; Falcone, A; Tonini, G | |
Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer | 1-gen-2008 | Vincenzi, B; Schiavon, G; Pantano, F; Santini, D; Tonini, G | |
Stevens-Johnson syndrome associated with reduced tear production complicating the use of cetuximab and panitunumab | 1-gen-2009 | Pantano, F; Silletta, M; Iovieno, A; Vincenzi, B; Santini, D; Galluzzo, S; Bonini, S; Tonini, G | |
PANCREAS CANCER | 1-gen-2009 | Tonini, G; Pantano, F | |
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population | 1-gen-2009 | Angeletti, S; Galluzzo, S; Santini, D; Ruzzo, A; Vincenzi, B; Ferraro, E; Spoto, C; Lorino, G; Graziano, N; Calvieri, A; Magnani, M; Graziano, F; Pantano, F; Tonini, G; Dicuonzo, G | |
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients | 1-gen-2009 | Pantano, F; Baldi, A; Santini, D; Vincenzi, B; Borzomati, D; Vecchio, Fm; Castri, F; Antinori, A; Caraglia, M; Magistrelli, P; Coppola, R; Tonini, G | |
Potential role of everolimus in inducing cholestasis | 1-gen-2010 | Pantano, F; Santini, D; Guida, F; Vincenzi, B; Tonini, G | |
CETUXIMAB: From bench to bedside | 1-gen-2010 | Vincenzi, B.; Zoccoli, A.; Pantano, F.; Venditti, O.; Galluzzo, S. | |
New molecular targets in bone metastases | 1-gen-2010 | Santini, D; Galluzzo, S; Zoccoli, A; Pantano, F; Fratto, Me; Vincenzi, B; Lombardi, L; Gucciardino, C; Silvestris, N; Riva, E; Rizzo, S; Russo, A; Maiello, E; Colucci, G; Tonini, G | |
TUMORI NEUROENDOCRINI | 1-gen-2011 | Tonini, G; Pantano, F | |
Monoclonal antibodies | 1-gen-2011 | Tonini, G; Imperatori, M; Zoccoli, A; Iuliani, M; Pantano, F | |
New targets, new drugs for metastatic bone pain: a new philosophy | 1-gen-2011 | Pantano, F; Zoccoli, A; Iuliani, M; Lanzetta, G; Vincenzi, B; Tonini, G; Santini, D | |
Emerging Therapeutic Targets in Osteoncology | 1-gen-2011 | Santini, D; Pantano, F; Vincenzi, B; Tonini, G | |
Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence | 1-gen-2011 | Tonini, G; Fratto, Me; Imperatori, M; Pantano, F; Vincenzi, B; Santini, D | |
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients | 1-gen-2011 | Santini, D; Schiavon, G; Vincenzi, B; Gaeta, L; Pantano, F; Russo, A; Ortega, C; Porta, C; Galluzzo, S; Armento, G; La Verde, N; Caroti, C; Treilleux, I; Ruggiero, A; Perrone, G; Addeo, R; Clezardin, P; Onetti Muda, A; Tonini, G | |
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases | 1-gen-2011 | Santini, D; Perrone, G; Roato, I; Godio, L; Pantano, F; Grasso, D; Russo, A; Vincenzi, B; Fratto, Me; Sabbatini, R; Della Pepa, C; Porta, C; Del Conte, A; Schiavon, G; Berruti, A; Tomasino, Rm; Papotti, M; Papapietro, N; Onetti Muda, A; Denaro, V; Tonini, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile